Shaanxi Key Laboratory of Natural Products & Chemical Biology, College of Chemistry & Pharmacy, Northwest A&F University, Yangling, Shaanxi 712100, People's Republic of China.
Key Laboratory of Plant Protection Resources and Pest Management of Ministry of Education, Key Laboratory of Integrated Pest Management on the Loess Plateau of Ministry of Agriculture and Rural Affairs, College of Plant Protection, Northwest A&F University, Yangling, Shaanxi 712100, People's Republic of China.
J Agric Food Chem. 2024 Mar 27;72(12):6691-6701. doi: 10.1021/acs.jafc.3c07567. Epub 2024 Mar 18.
To accelerate the development of novel fungicides, a variety of -(pyrazol-5-yl)benzamide derivatives with a diphenylamine moiety were designed and synthesized using a pharmacophore recombination strategy based on the structure of pyrazol-5-yl-aminophenyl-benzamides. The bioassay results demonstrated that most of the target compounds had excellent antifungal activities against , , and . In particular, compound exhibited remarkable activity against (EC = 0.37 mg/L), which was similar to that of fluxapyroxad (EC = 0.27 mg/L). In addition, compound (EC = 1.32 mg/L) was observed to be more effective against than fluxapyroxad (EC = 12.8 mg/L) and comparable to trifloxystrobin (EC = 1.62 mg/L). Furthermore, compound demonstrated remarkable protective antifungal properties against , with an inhibition rate of 96.8% at 100 mg/L, which was close to that of fluxapyroxad (99.6%). Compounds (66.7%) and (62.9%) exhibited good antifungal effects against at 100 mg/L, which were superior to that of fluxapyroxad (11.1%) but lower than that of trifloxystrobin (88.9%). The succinate dehydrogenase (SDH) enzymatic inhibition assay was conducted to confirm the mechanism of action. Molecular docking analysis further revealed that compound has significant hydrogen-bonding, π-π, and p-π conjugation interactions with ARG 43, SER 39, TRP 173, and TYR 58 in the binding site of SDH, and the binding mode was similar to that of the commercial fungicide fluxapyroxad. All of the results suggest that compound could be a potential SDH inhibitor, offering a valuable reference for future studies.
为了加速新型杀菌剂的开发,我们采用基于吡唑-5-基-氨基苯基-苯甲酰胺结构的药效团重组策略,设计并合成了一系列带有二苯胺部分的-(吡唑-5-基)苯甲酰胺衍生物。生物测定结果表明,大多数目标化合物对、和具有优异的抗真菌活性。特别是,化合物对(EC = 0.37 mg/L)表现出显著的活性,与氟环唑(EC = 0.27 mg/L)相当。此外,化合物(EC = 1.32 mg/L)对的活性优于氟环唑(EC = 12.8 mg/L),与肟醚菌胺(EC = 1.62 mg/L)相当。此外,化合物对(EC = 100 mg/L)表现出显著的保护抗真菌特性,抑制率为 96.8%,接近于氟环唑(99.6%)。化合物(66.7%)和(62.9%)在 100 mg/L 时对表现出良好的抗真菌效果,优于氟环唑(11.1%)但低于肟醚菌胺(88.9%)。进行了琥珀酸脱氢酶(SDH)酶抑制测定以确认作用机制。分子对接分析进一步表明,化合物与 SDH 结合位点中的 ARG 43、SER 39、TRP 173 和 TYR 58 具有显著的氢键、π-π 和 p-π 共轭相互作用,结合模式与商业杀菌剂氟环唑相似。所有结果表明,化合物可能是一种潜在的 SDH 抑制剂,为未来的研究提供了有价值的参考。